Thyroid cancer is one of the most treatable forms of cancer. It does, however, mean a lifetime of careful monitoring and testing. This often meant that, at least once a year, thyroid cancer patients would have to go off their thyroid hormones to prepare for the necessary tests. For weeks and often a few months, patients would experience symptoms of hypothyroidism, which may cause great discomfort and may even disrupt home life and work. Some patients may now have an alternative. Using Thyrogen^® (thyrotropin alfa for injection) in combination with common imaging and laboratory tests, provides patients with an alternative to thyroid hormone withdrawal and the difficulties it can cause while giving doctors an effective follow-up tool in the management of well-differentiated thyroid cancer. For more details, please read the full product information.